- Amended Statement of Ownership (SC 13G/A)
February 17 2009 - 4:12PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
Information Statement Pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
Targanta Therapeutics Corporation
Common Stock, par value $0.0001 per share
|
(Title of Class of Securities)
|
87612C100
December 31, 2008
|
(Date of Event Which Requires Filing of this Statement)
|
Check the appropriate box to designate the
rule pursuant to which this schedule is filed:
¨
Rule 13d-1(b)
¨
Rule 13d-1(c)
x
Rule 13d-1(d)
*
|
|
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter disclosures provided in a prior cover page.
|
The information required on the
remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
CUSIP No. 87612C100
|
|
13G
|
|
Page 2 of 4 Pages
|
|
|
|
|
|
1.
|
|
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Brookside Capital Partners Fund, L.P.
EIN No.: 04-3313066
|
|
|
2.
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
¨
(b)
¨
|
|
|
3.
|
|
SEC USE ONLY
|
|
|
4.
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|
|
|
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5. SOLE VOTING POWER
2,771,682 shares
|
|
6. SHARED VOTING POWER
0
shares
|
|
7. SOLE DISPOSITIVE POWER
2,771,682 shares
|
|
8. SHARED DISPOSITIVE POWER
0
shares
|
|
|
|
|
|
9.
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,771,682 shares
|
|
|
10.
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
¨
|
11.
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
13.14%*
|
|
|
12.
|
|
TYPE OF REPORTING PERSON
PN
|
|
|
*
|
Percentage is calculated using as the numerator, the total number of shares of Common Stock held by the Reporting Person (which includes a warrant to purchase 103,695 shares of
Common Stock), and as the denominator, 20,988,387 shares of Common Stock outstanding, plus the 103,695 shares of Common Stock held by the Reporting Person in the form of a warrant.
|
Page 2 of 4 Pages
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 1
|
|
(a).
|
|
Name of Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The name of the issuer to which this filing on Schedule 13G relates is Targanta Therapeutics Corporation (the Company).
|
|
|
|
|
|
|
|
|
|
Item 1
|
|
(b).
|
|
Address of Issuers Principal Executive Offices
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The principal executive offices of the Company are located at 222 Third Street, Suite 2300, Cambridge, Massachusetts 02142.
|
|
|
|
|
|
|
|
|
|
Item 2
|
|
(a).
|
|
Name of Person Filing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This Statement is being filed on behalf of Brookside Capital Partners Fund, L.P., a Delaware limited partnership (the Brookside Fund). Brookside Capital Investors,
L.P., a Delaware limited partnership (Brookside Investors) is the sole general partner of the Brookside Fund. Brookside Capital Management, LLC, a Delaware limited liability company (Brookside Management), is the sole general
partner of Brookside Investors. Mr. Domenic J. Ferrante is the sole managing member of Brookside Management.
|
|
|
|
|
|
|
|
|
|
Item 2
|
|
(b).
|
|
Address of Principal Business Office or, if none, Residence
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The principal business address of each of the Brookside Fund, Brookside Investors, Brookside Management and Mr. Ferrante is 111 Huntington Avenue, Boston, Massachusetts 02199.
|
|
|
|
|
|
|
|
|
|
Item 2
|
|
(c).
|
|
Citizenship
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Each of the Brookside Fund, Brookside Investors and Brookside Management is organized under the laws of the State of Delaware. Mr. Ferrante is a citizen of the United
States.
|
|
|
|
|
|
|
|
|
|
Item 2
|
|
(d).
|
|
Title of Class of Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The class of equity securities of the Company to which this filing on Schedule 13G relates is Common Stock, par value $0.0001 (Common Stock).
|
|
|
|
|
|
|
|
|
|
Item 2
|
|
(e).
|
|
CUSIP Number
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The CUSIP number of the Companys Common Stock is 87612C100.
|
|
|
|
|
|
|
|
Item 3.
|
|
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
Not applicable.
|
|
|
|
|
|
|
|
|
(a)
|
|
¨
|
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
|
|
|
|
|
|
(b)
|
|
¨
|
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 73c).
|
|
|
|
|
|
|
(c)
|
|
¨
|
|
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
|
(d)
|
|
¨
|
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
|
|
|
|
|
|
(e)
|
|
¨
|
|
An investment adviser in accordance with §13d-1(b)(1)(ii)(E).
|
|
|
|
|
|
|
(f)
|
|
¨
|
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
|
|
|
|
|
|
|
(g)
|
|
¨
|
|
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
|
|
|
|
|
|
|
(h)
|
|
¨
|
|
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
|
|
|
|
|
|
|
(i)
|
|
¨
|
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
|
|
|
|
|
|
|
(j)
|
|
¨
|
|
Group, in accordance with §240.13d-1(b)(1)(ii)(J).
|
|
|
|
|
|
|
|
|
¨
|
|
If this statement is filed pursuant to §240.13d-1(c), check this box
.
|
Page 3 of 4 Pages
|
|
|
|
|
|
|
|
|
|
|
Item 4.
|
|
Ownership
|
|
|
|
|
|
|
|
|
|
Item 4
|
|
(a).
|
|
Amount beneficially owned
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of the close of business on December 31, 2008, the Brookside Fund owned 2,771,682 shares of Common Stock of the Company (including a warrant to purchase 103,695 shares of
Common Stock of the Company). The Brookside Fund acts by and through its general partner, Brookside Investors. Brookside Investors acts by and through its general partner, Brookside Management. Mr. Domenic J. Ferrante is the managing member of
Brookside Management and thus is the controlling person of Brookside Management. No person other than the respective owner referred to herein of the Common Stock is known to have the right to receive or the power to direct the receipt of dividends
from or the proceeds from the sale of such Common Stock.
|
|
|
|
|
|
|
|
|
|
Item 4
|
|
(b).
|
|
Percent of Class
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of the close of business on December 31, 2008, the Brookside Fund was the beneficial owner of 13.14% of the Common Stock of the Company. The aggregate percentage of Common
Stock reported owned by the Brookside Fund is based upon 20,988,387 shares of Common Stock outstanding, which is the total number of shares of Common Stock outstanding as of October 31, 2008, based on representations made in the Companys Form
10-Q filed November 12, 2008 with the Securities and Exchange Commission.*
|
|
|
|
|
|
|
|
|
|
Item 4
|
|
(c).
|
|
Number of shares as to which such person has
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
|
sole power to vote or to direct the vote:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,771,682 shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii)
|
|
shared power to vote or to direct the vote:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0 shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(iii)
|
|
sole power to dispose or to direct the disposition of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,771,682 shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(iv)
|
|
shared power to dispose or to direct the disposition of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0 shares
|
|
|
|
|
*
|
Percentage is calculated using as the numerator, the total number of shares of Common Stock held by the Reporting Person (which includes a warrant to purchase 103,695 shares of
Common Stock), and as the denominator, 20,988,387 shares of Common Stock outstanding, plus the 103,695 shares of Common Stock held by the Reporting Person in the form of a warrant.
|
|
|
|
|
|
|
|
|
|
|
|
Item 5.
|
|
Ownership of Five Percent or Less of a Class
|
|
|
|
|
|
|
|
Not Applicable.
|
|
|
|
|
|
|
Item 6.
|
|
Ownership of More than Five Percent on Behalf of Another Person
|
|
|
|
|
|
|
|
|
|
|
Not Applicable.
|
|
|
|
|
|
|
Item 7.
|
|
Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company
:
|
|
|
|
|
Not Applicable.
|
|
|
|
|
Item 8.
|
|
Identification and Classification of Members of the Group
|
|
|
|
|
|
|
|
|
|
|
Not Applicable.
|
|
|
|
|
|
|
|
|
Item 9.
|
|
Notice of Dissolution of Group
|
|
|
|
|
|
|
|
|
|
|
Not Applicable.
|
|
|
|
|
|
|
|
|
Item 10.
|
|
Certification
|
|
|
|
|
|
|
|
|
|
|
By signing below, the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of
or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
|
|
|
|
|
Dated: February 17, 2009
|
|
|
BROOKSIDE CAPITAL PARTNERS FUND, L.P.
|
|
|
By:
|
|
/s/ Domenic J. Ferrante
|
Name:
|
|
Domenic J. Ferrante
|
Title:
|
|
Managing Director
|
Page 4 of 4 Pages
Targanta Therapeutics Corp (MM) (NASDAQ:TARG)
Historical Stock Chart
From Jul 2024 to Aug 2024
Targanta Therapeutics Corp (MM) (NASDAQ:TARG)
Historical Stock Chart
From Aug 2023 to Aug 2024